Resources

Past Presentation

Diabetes and HCV | December 9, 2021

Date of Presentation: December 9, 2021

Type: Past Presentation  

Program: Diabetes ECHO Program  

Keywords: #hcc  #hcv and diabetes  #hepatitis c  #hepatocellular carcinoma  #type 2 diabetes  

In this video, Dr. Carol Greenlee, endocrinologist, discusses management of type 2 diabetes in patients with Hepatitis C Virus (HCV). Dr. Greenlee provides an overview of how HCV can potentially induce or aggravate diabetes and what to be aware of when caring for a patient with diabetes who is undergoing treatment for HCV. She also discusses what to expect for patients with diabetes post-HCV elimination and risk factors for hepatocellular carcinoma (HCC).

For further information about HCC, please visit here.

Recording:

Presented by:

Mary Carol Greenlee, MD, FACP, FACE

Mary Carol Greenlee, MD, FACP, FACE, is board-certified in Internal Medicine and Endocrinology, Diabetes and Metabolism and is in private practice at Western Slope Endocrinology in Grand Junction, Colorado. She is currently serving on the Endocrine Society Council after several years on the Society’s Clinical Affairs Core Committee. She has a special interest in care delivery issues and has been actively involved with the collaborative project sponsored by the Endocrine Society to develop tools to assist with the transition from pediatric to adult care for patients with endocrine disorders.

Resources Provided:

Date added: December 13, 2021